Viewing Study NCT00895102


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-03-06 @ 9:43 PM
Study NCT ID: NCT00895102
Status: COMPLETED
Last Update Posted: 2010-10-13
First Post: 2009-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers
Sponsor: Abbott
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HCV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioavailability (BA) View
None Single Ascending Dose (SAD) View